CN Patent
CN114149357B — 一种γ晶型培哚普利精氨酸盐的制备方法
Assigned to Jiangsu Sinobiopharma Co ltd · Expires 2024-06-25 · 2y expired
What this patent protects
本发明提出的是一种γ晶型培哚普利精氨酸盐的制备方法,将培哚普利和L‑精氨酸加入水中,搅拌溶清后过滤,将滤液与有机溶剂以滴加方式混合,滴加完毕后降至室温搅拌析晶1~2h,抽滤得滤饼,将滤饼淋洗,抽干,烘干滤饼即得γ晶型培哚普利精氨酸盐。该方法无需低温、冻干等操作对设备无特殊要求,也无需回流或加热操作,析晶温度适用范围较广,得到的产品好过滤,易分离,且质量水平较高。
USPTO Abstract
本发明提出的是一种γ晶型培哚普利精氨酸盐的制备方法,将培哚普利和L‑精氨酸加入水中,搅拌溶清后过滤,将滤液与有机溶剂以滴加方式混合,滴加完毕后降至室温搅拌析晶1~2h,抽滤得滤饼,将滤饼淋洗,抽干,烘干滤饼即得γ晶型培哚普利精氨酸盐。该方法无需低温、冻干等操作对设备无特殊要求,也无需回流或加热操作,析晶温度适用范围较广,得到的产品好过滤,易分离,且质量水平较高。
Drugs covered by this patent
- Caduet (Amlodipine Besylate) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.